
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 7.060 | 7.060 | 0.000 |
Shares | 93.190 | 93.190 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.718 | 19.266 |
Price to Book | 2.897 | 3.030 |
Price to Sales | 4.031 | 2.636 |
Price to Cash Flow | 12.282 | 11.426 |
Dividend Yield | 0.260 | 2.154 |
5 Years Earnings Growth | 30.208 | 12.590 |
Number of long holdings: 139
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Neurocrine | US64125C1099 | 2.39 | 125.01 | -0.47% | |
AbbVie | US00287Y1091 | 2.28 | 198.05 | -0.41% | |
Gilead | US3755581036 | 2.24 | 119.41 | +8.28% | |
Biomarin Pharma | US09061G1013 | 2.23 | 57.33 | -3.58% | |
United Therapeutics | US91307C1027 | 2.18 | 301.50 | +0.69% | |
Biogen | US09062X1037 | 2.18 | 130.67 | +2.29% | |
Moderna | US60770K1079 | 2.17 | 26.12 | -1.84% | |
Sarepta | US8036071004 | 2.17 | 18.23 | +1.50% | |
Amgen | US0311621009 | 2.14 | 288.23 | +1.24% | |
Incyte | US45337C1027 | 2.14 | 78.39 | +0.24% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
E Fund Blue Chip Selected Mixed | 34.94B | 5.60 | -5.34 | - | ||
E Fund CSI300 ETF Feeder Fund | 19.16B | 5.35 | 1.62 | 2.97 | ||
E Fund SSE50 Index | 18.32B | 6.64 | 1.76 | 7.41 | ||
E Fund Consumer Sector | 16.85B | -6.99 | -6.05 | 9.97 | ||
E Fund Mid Small Cap | 12.78B | 3.73 | -5.95 | 9.97 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review